JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2008, 57(4):170-176

A study of the properties of tablets from two types of directly compressible xylitol

J. Mužíková, H. Komínková
Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Pharmaceutical Technology

The paper deals with the study of tensile strength and disintegration time of tablets from two types of directly compressible xylitol, Xylitab 100 and Xylitab 200, in dependence on compression force, addition of two types of lubricants in one concentration, and two types of active ingredients. Tablets were compressed using the compression forces of 6, 8, and 10 kN, in the case of tableting materials with active ingredients, only 10 kN. The lubricants employed were magnesium stearate and sodium stearyl fumarate at the concentration of 1%, the active ingredients, ascorbic acid and acetylsalicylic acid at the concentration of 50%. The strength of tablets increased with compression force. Compacts from Xylitab 100 possessed a higher strength and it was more decreased by added lubricants than compacts from Xylitab 200, in which, in contrast to Xylitab 100, magnesium stearate decreased strength more. Disintegration time was longer in the case of compacts with Xylitab 200; it increased with compression force, except in those with Xylitab 200 with magnesium stearate and it was prolonged in the case of the presence of lubricants, more in the case of magnesium stearate . Compacts with both active ingredients were stronger and possessed a shorter disintegration time in the case of Xylitab 100. A significantly higher strength and a longer disintegration time was observed in the tablets with acetylsalicylic acid.

Keywords: Xylitab 100; Xylitab 200; lubricants; tensile strength of tablets; time of disintegration
Grants and funding:

The study was supported by the grant MSM 0021620822 and by the firm Danisco, which supplied the samples of the dry binders tested.

Received: June 27, 2024; Accepted: July 2, 2008; Published: April 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mužíková J, Komínková H. A study of the properties of tablets from two types of directly compressible xylitol. Čes. slov. farm. 2008;57(4):170-176.
Download citation

References

  1. Kibbe, H. A.: Handbook of pharmaceutical excipients. Third ed., American Pharmaceutical Association and the Pharmaceutical Press, Washington, London, 2000, 602-605.
  2. Garr, J. S. M., Rubinstein, M. H.: Int. J. Pharm., 1990; 64, 223-226. Go to original source...
  3. Danisco: Excipients 2005, Firm lit., http://www.danisco.com/cms/connect/corporate/products%20and%20services/pharma%20and%20healtcare/dietary%20supplements/excipients/, cit. February 2008
  4. Morris, L. E., Moore, J. C., Schwartz, J. B.: Drug Dev. Ind. Pharm., 1996; 22, 925-932. Go to original source...
  5. Bolhuis, G. K., Armstrong, N. A.: Pharm. Dev. Technol., 2006; 11, 111-124. Go to original source... Go to PubMed...
  6. Fell, J. T., Newton, J. M.: J. Pharm. Sci., 1970; 59, 688-691. Go to original source... Go to PubMed...
  7. Bos, C. E., Bolhuis, H., Van Doorne, Lerk, C. F.: Pharm. Weekbl., 1987; Sci. Ed. 9, 274-282. Go to original source... Go to PubMed...
  8. Ph.B. MMV, Grada Publishing, a.s., Prague, 2005, vol. I, s. 269.
  9. Belousov, V. A.: Khim. Farm. Zh., 1976; 10, 105-111. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.